Pancreatic Cancer Research

Journal articleWorld J Gastrointest Oncol2017

Neoadjuvant therapy for resectable pancreatic cancer.

Journal
World J Gastrointest Oncol
Published
1 December 2017
Citations
15
Type
Article
License
cc by-nc

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract cc by-nc

The use of neoadjuvant therapies has played a major role for borderline resectable and locally advanced pancreatic cancers (PCs). For this group of patients, preoperative chemotherapy or chemoradiation has increased the likelihood of surgery with negative resection margins and overall survival. … Excerpt only: this text is the publisher’s. Read it in full at the source.